Skip to main content

Rothblatt Martine A's Form 4 filing

United Therapeutics Corp (UTHR) · filed Sep 2, 2026

Accession no.
0001106578-26-000133
Filed
Sep 2, 2026, 4:34 PM ET
Trade date
Sep 1, 2026
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 8 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.88M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rothblatt Martine ACIK 0001106578Director, Officer (Chairperson & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 1, 2026Common StockMOption exerciseAcquired+9,500$135.42+$1,286,490333,943Indirect
Sep 1, 2026Common StockSSaleDisposed−320$510.72−$163,431.71333,623Indirect
Sep 1, 2026Common StockSSaleDisposed−825$511.95−$422,359.16332,798Indirect
Sep 1, 2026Common StockSSaleDisposed−1,732$513.12−$888,721.42331,066Indirect
Sep 1, 2026Common StockSSaleDisposed−3,454$514.09−$1,775,676.19327,612Indirect
Sep 1, 2026Common StockSSaleDisposed−1,620$514.98−$834,272.46325,992Indirect
Sep 1, 2026Common StockSSaleDisposed−1,469$516.03−$758,048.8324,523Indirect
Sep 1, 2026Common StockSSaleDisposed−80$516.62−$41,329.6324,443Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 1, 2026Common StockMOption exerciseDisposed−9,500$0.00$018,410Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)